Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

NCT01735175 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Neutropenic Complications
Breast Neoplasms
Chemotherapy-induced Neutropenia
Chemotherapeutic Toxicity

Interventions

DRUG: LA-EP2006
DRUG: Neulasta®

Sponsor

Sandoz

Collaborators

[object Object]